Praxis Precision Medicines, Inc.
PRAX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689548
No open-market purchases or sales by Praxis Precision Medicines, Inc. insiders were filed in the last 90 days; 309 institutions reported holding it in 13F filings for Q2 2026, worth $11.3B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Praxis Precision Medicines, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 108
- +13 vs. Q2 2022
- Shares held
- 42.1M
- −974.0K (−2.3%) vs. Q2 2022
- Total value
- $95.7M
- −$9.87M (−9.4%) vs. Q2 2022
- New holders
- 26
- 29 more added
- Sold out
- 13
- 31 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRAX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 309 | $11.3B |
| Q1 2026 | 291 | $10.2B |
| Q4 2025 | 250 | $8.69B |
| Q3 2025 | 152 | $1.31B |
| Q2 2025 | 144 | $1.02B |
| Q1 2025 | 150 | $889.3M |
| Q4 2024 | 162 | $1.67B |
| Q3 2024 | 134 | $1.09B |
| Q2 2024 | 113 | $762.1M |
| Q1 2024 | 111 | $971.3M |
| Q4 2023 | 60 | $178.6M |
| Q3 2023 | 74 | $195.6M |
| Q2 2023 | 78 | $134.6M |
| Q1 2023 | 87 | $43.1M |
| Q4 2022 | 104 | $108.1M |
| Q3 2022 | 108 | $95.7M |
| Q2 2022 | 95 | $105.5M |
| Q1 2022 | 103 | $463.4M |
| Q4 2021 | 100 | $863.1M |
| Q3 2021 | 93 | $791.5M |
| Q2 2021 | 80 | $751.0M |
| Q1 2021 | 68 | $1.19B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Praxis Precision Medicines, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 1,496,324 | $3.40M | 0.10% | +1,286,224+612.2% | Added |
| Vanguard Group Inc | 1,804,353 | $4.10M | 0.00% | −736,945−29.0% | Reduced |
| Adage Capital Partners GP, L.L.C. | 2,256,041 | $5.12M | 0.01% | +500,000+28.5% | Added |
| Vida Ventures Advisors, LLC | 2,939,329 | $6.67M | 5.99% | 00.0% | Unchanged |
| BlackRock Inc. | 3,244,202 | $7.37M | 0.00% | +273,440+9.2% | Added |
| PFM Health Sciences, LP | 3,458,525 | $7.85M | 0.30% | +161,178+4.9% | Added |
| Eventide Asset Management, LLC | 3,518,062 | $7.99M | 0.16% | 00.0% | Unchanged |
| Blackstone Group Inc. | 4,894,109 | $11.1M | 0.04% | 00.0% | Unchanged |
| Woodline Partners LP | 0 | $0 | 0.00% | −308,746−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −229,840−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −156,707−100.0% | Sold out |
| Endurant Capital Management LP | 0 | $0 | 0.00% | −79,097−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −74,468−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −26,064−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −21,050−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −1,345−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −205−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −550−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −207−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −408−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −115−100.0% | Sold out |